Editas Medicine (NASDAQ:EDIT – Get Free Report) and Genmab A/S (NASDAQ:GMAB – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk. Institutional & Insider Ownership 71.9% of Editas Medicine […]

Apyx Medical (NASDAQ:APYX – Get Free Report) and Merit Medical Systems (NASDAQ:MMSI – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability. Institutional & Insider Ownership 55.3% of Apyx […]